Mayengbam Shyamananda Singh, Singh Abhijeet, Yaduvanshi Himanshi, Bhati Firoz Khan, Deshmukh Bhavana, Athavale Dipti, Ramteke Pranay L, Bhat Manoj Kumar
National Centre for Cell Science, Department of Biotechnology, Government of India, Savitribai Phule Pune University Campus, Ganeshkhind, Pune, 411 007, India.
Cancer Metab. 2023 Sep 13;11(1):15. doi: 10.1186/s40170-023-00315-1.
Hypercholesterolemia is often correlated with obesity which is considered a risk factor for various cancers. With the growing population of hypercholesterolemic individuals, there is a need to understand the role of increased circulatory cholesterol or dietary cholesterol intake towards cancer etiology and pathology. Recently, abnormality in the blood cholesterol level of colon cancer patients has been reported. In the present study, we demonstrate that alteration in cholesterol levels (through a high-cholesterol or high-fat diet) increases the incidence of chemical carcinogen-induced colon polyp occurrence and tumor progression in mice. At the cellular level, low-density lipoprotein cholesterol (LDLc) and high-density lipoprotein cholesterol (HDLc) promote colon cancer cell proliferation by tuning the cellular glucose and lipid metabolism. Mechanistically, supplementation of LDLc or HDLc promotes cellular glucose uptake, and utilization, thereby, causing an increase in lactate production by colon cancer cells. Moreover, LDLc or HDLc upregulates aerobic glycolysis, causing an increase in total ATP production through glycolysis, and a decrease in ATP generation by OXPHOS. Interestingly, the shift in the metabolic status towards a more glycolytic phenotype upon the availability of cholesterol supports rapid cell proliferation. Additionally, an alteration in the expression of the molecules involved in cholesterol uptake along with the increase in lipid and cholesterol accumulation was observed in cells supplemented with LDLc or HDLc. These results indicate that colon cancer cells directly utilize the cholesterol associated with LDLc or HDLc. Moreover, targeting glucose metabolism through LDH inhibitor (oxamate) drastically abrogates the cellular proliferation induced by LDLc or HDLc. Collectively, we illustrate the vital role of cholesterol in regulating the cellular glucose and lipid metabolism of cancer cells and its direct effect on the colon tumorigenesis.
高胆固醇血症常与肥胖相关,而肥胖被认为是多种癌症的危险因素。随着高胆固醇血症患者数量的不断增加,有必要了解循环胆固醇升高或饮食中胆固醇摄入量对癌症病因和病理的作用。最近,有报道称结肠癌患者血液胆固醇水平异常。在本研究中,我们证明胆固醇水平的改变(通过高胆固醇或高脂肪饮食)会增加化学致癌物诱导的小鼠结肠息肉发生率和肿瘤进展。在细胞水平上,低密度脂蛋白胆固醇(LDLc)和高密度脂蛋白胆固醇(HDLc)通过调节细胞葡萄糖和脂质代谢促进结肠癌细胞增殖。从机制上讲,补充LDLc或HDLc可促进细胞葡萄糖摄取和利用,从而导致结肠癌细胞乳酸生成增加。此外,LDLc或HDLc上调有氧糖酵解,导致通过糖酵解产生的总ATP增加,而氧化磷酸化产生的ATP减少。有趣的是,在有胆固醇的情况下,代谢状态向更具糖酵解表型的转变支持细胞快速增殖。此外,在补充LDLc或HDLc的细胞中观察到胆固醇摄取相关分子表达的改变以及脂质和胆固醇积累的增加。这些结果表明结肠癌细胞直接利用与LDLc或HDLc相关的胆固醇。此外,通过乳酸脱氢酶抑制剂(草氨酸盐)靶向葡萄糖代谢可显著消除LDLc或HDLc诱导的细胞增殖。总的来说,我们阐述了胆固醇在调节癌细胞的细胞葡萄糖和脂质代谢中的重要作用及其对结肠肿瘤发生的直接影响。